Who owns Glycomimetics?
- Ticker: GLYC
- CUSIP Number: 38000q102
Tip: Access positions for across all investors
Analyze quarterly positions in Glycomimetics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Glycomimetics stock
Who bought or sold Glycomimetics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 9.5M | $29M | 0% | Mar 2024 |
|
| Artal Group | 8.6M | $26M | 0% | Mar 2024 |
|
| NEA Management Company | 3.8M | $12M | -20% | Mar 2024 |
|
| Octagon Capital Advisors | 3.0M | $9.0M | 0% | Mar 2024 |
|
| Vanguard Group | 2.8M | $8.3M | 14% | Mar 2024 |
|
| Axa | 1.6M | $4.8M | -2% | Mar 2024 |
|
| Goldman Sachs Group | 1.1M | $3.3M | 21% | Mar 2024 |
|
| Susquehanna International | 1.0M | $3.1M | 310% | Mar 2024 |
|
| Millennium Management | 747k | $2.2M | 1821% | Mar 2024 |
|
| BlackRock | 733k | $2.2M | 0% | Mar 2024 |
|
| Geode Capital Management | 505k | $1.5M | 10% | Mar 2024 |
|
| Balyasny Asset Management | 371k | $1.1M | 100% | Mar 2024 |
|
| Ikarian Capital | 346k | $1.0M | 100% | Mar 2024 |
|
| Acadian Asset Management | 331k | $991k | -61% | Mar 2024 |
|
| Jane Street | 289k | $868k | 406% | Mar 2024 |
|
| Qube Research & Technologies | 220k | $661k | 55125% | Mar 2024 |
|
| Marshall Wace | 218k | $653k | 1588% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 181k | $542k | 26% | Mar 2024 |
|
| Bridgeway Capital Management | 169k | $506k | -2% | Mar 2024 |
|
| Verition Fund Management | 162k | $487k | 100% | Mar 2024 |
|
| Hrt Financial | 156k | $467k | 100% | Mar 2024 |
|
| Man Group | 150k | $450k | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 139k | $417k | 100% | Mar 2024 |
|
| Citigroup | 138k | $413k | 539% | Mar 2024 |
|
| Northern Trust | 129k | $386k | 21% | Mar 2024 |
|
| Sargent Investment Group | 108k | $324k | 86% | Mar 2024 |
|
| Morgan Stanley | 103k | $309k | 155% | Mar 2024 |
|
| Adage Capital Partners GP | 100k | $300k | 100% | Mar 2024 |
|
| Boothbay Fund Management | 91k | $274k | 100% | Mar 2024 |
|
| Simplex Trading | 91k | $271k | 25% | Mar 2024 |
|
| Jpmorgan Chase & Co | 85k | $254k | 5146% | Mar 2024 |
|
| Citadel Advisors | 84k | $251k | 243% | Mar 2024 |
|
| American Century Companies | 64k | $191k | 100% | Mar 2024 |
|
| LPL Financial | 58k | $174k | 346% | Mar 2024 |
|
| Point72 Asia | 52k | $156k | 100% | Mar 2024 |
|
| Bank of America Corporation | 51k | $153k | 155% | Mar 2024 |
|
| Intellectus Partners | 51k | $152k | 0% | Mar 2024 |
|
| Cubist Systematic Strategies | 50k | $149k | 100% | Mar 2024 |
|
| Letko, Brosseau & Associates | 45k | $136k | 0% | Mar 2024 |
|
| Y-Intercept | 43k | $129k | 100% | Mar 2024 |
|
| Ieq Capital | 38k | $115k | 0% | Mar 2024 |
|
| Leucadia National Corporation | 38k | $115k | 100% | Mar 2024 |
|
| ExodusPoint Capital Management | 36k | $107k | 100% | Mar 2024 |
|
| Virtu Financial | 34k | $81k | 100% | Dec 2023 |
|
| Two Sigma Advisers | 29k | $88k | -82% | Mar 2024 |
|
| Group One Trading | 29k | $86k | 1% | Mar 2024 |
|
| Belvedere Trading | 26k | $76k | 100% | Mar 2024 |
|
| Tower Research Capital | 24k | $71k | 407% | Mar 2024 |
|
| Brevan Howard Capital Management | 23k | $70k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 23k | $70k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 22k | $67k | 0% | Mar 2024 |
|
| Squarepoint Ops | 20k | $61k | 100% | Mar 2024 |
|
| SG Americas Securities | 19k | $56k | 100% | Mar 2024 |
|
| GSA Capital Partners | 18k | $55k | -91% | Mar 2024 |
|
| CTC Alternative Strategies | 18k | $53k | 100% | Mar 2024 |
|
| Tobias Financial Advisors | 15k | $45k | 0% | Mar 2024 |
|
| LMR Partners | 14k | $42k | 100% | Mar 2024 |
|
| Pine Valley Investments Ltd Liability | 13k | $38k | 0% | Mar 2024 |
|
| Hartford Financial Management | 3.5k | $11k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 2.0k | $6.0k | 100% | Mar 2024 |
|
| UBS Group | 1.5k | $4.5k | 120% | Mar 2024 |
|
| Rhumbline Advisers | 1.0k | $3.1k | 0% | Mar 2024 |
|
| Old Point Trust & Financial Services N A | 500.00 | $1.5k | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 481.00 | $1.4k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 383.00 | $1.1k | 2% | Mar 2024 |
|
| Barclays | 76.00 | $0 | 0% | Mar 2024 |
|
| FMR | 67.00 | $201.000000 | 100% | Mar 2024 |
|
Who sold out of Glycomimetics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Mjp Associates | Dec 2023 | 101k | $238k |
| Advisor OS | Dec 2023 | 101k | $238k |
| Franklin Resources | Dec 2023 | 96k | $226k |
| Two Sigma Investments | Dec 2023 | 60k | $141k |
| XTX Topco | Sep 2023 | 33k | $49k |
| Bank of New York Mellon | Dec 2023 | 25k | $58k |
| 683 Capital Management | Dec 2023 | 19k | $46k |
| ORG Partners | Dec 2023 | 500.00 | $1.2k |